Synergy's Safety Profile Should Boost Trulance Uptake, Takeover Prospects Remain Favorable By: Benzinga via Benzinga March 02, 2017 at 14:53 PM EST Rodman & Renshaw reiterated its Buy rating on Synergy Pharmaceuticals Inc (NASDAQ: SGYP), saying the company’s ... Read More >> Related Stocks: Astrazeneca Plc ADR Novartis Ag ADR Shire Plc Ads Synergy Pharma Takeda Pharma